Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. | Metabolites | 2022 | 35736421 | PubTator, text mining | PubMed |
| Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer. | Front Oncol | 2022 | 35719954 | PubTator, text mining | PubMed |
| Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2022 | 35719135 | PubTator, text mining | PubMed |
| Further characterization of tryptophan metabolism and its dysregulation in fibroids. | F S Sci | 2022 | 35715314 | PubTator, text mining | PubMed |
| Fumarate suppresses B-cell activation and function through direct inactivation of LYN. | Nat Chem Biol | 2022 | 35710616 | PubTator, text mining | PubMed |
| Case of metachronous clear cell bladder metastasis on low risk localized renal cell carcinoma patient. | Int J Surg Case Rep | 2022 | 35709632 | PubTator, text mining | PubMed |
| Mechanisms that regulate the activities of TET proteins. | Cell Mol Life Sci | 2022 | 35705880 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner. | J Clin Lab Anal | 2022 | 35689537 | PubTator, text mining | PubMed |
| Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis. | Cancers (Basel) | 2022 | 35681635 | PubTator, text mining | PubMed |
| Functional and phylogenetic analyses of camel rumen microbiota associated with different lignocellulosic substrates. | NPJ Biofilms Microbiomes | 2022 | 35676509 | PubTator, text mining | PubMed |
| Papillary renal cell carcinoma: current and controversial issues. | Curr Opin Urol | 2022 | 35674688 | PubTator, text mining | PubMed |
| The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. | Nat Cell Biol | 2022 | 35668135 | PubTator, text mining | PubMed |
| Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases. | Hum Pathol | 2022 | 35659509 | PubTator, text mining | PubMed |
| Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases. | Front Mol Biosci | 2022 | 35647032 | PubTator, text mining | PubMed |
| Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas. | Reprod Sci | 2022 | 35641855 | PubTator, text mining | PubMed |
| High-intensity interval training remodels the proteome and acetylome of human skeletal muscle. | Elife | 2022 | 35638262 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers. | Nutrients | 2022 | 35631199 | PubTator, text mining | PubMed |
| A Multi-Omics Approach to Evaluate the Toxicity Mechanisms Associated with Silver Nanoparticles Exposure. | Nanomaterials (Basel) | 2022 | 35630985 | PubTator, text mining | PubMed |
| Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosis as an Attractive Theranostic Outlook for Tackling Non-Small Lung Cancer: A Mini Review. | Materials (Basel) | 2022 | 35629488 | PubTator, text mining | PubMed |
| Lack of Major Genome-Wide DNA Methylation Changes in Succinate-Treated Human Epithelial Cells. | Int J Mol Sci | 2022 | 35628470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=37